Bioactivity and structure for cranberry proanthocyanidins

蔓越莓原花青素的生物活性和结构

基本信息

  • 批准号:
    7295747
  • 负责人:
  • 金额:
    $ 17.84万
  • 依托单位:
  • 依托单位国家:
    美国
  • 项目类别:
  • 财政年份:
    2006
  • 资助国家:
    美国
  • 起止时间:
    2006-09-30 至 2009-08-31
  • 项目状态:
    已结题

项目摘要

DESCRIPTION (provided by applicant): Cranberry Proanthocyanidins may be the constituents responsible for the association between consumption of cranberry juice and decreased risks of urinary tract infections because these compounds prevent the adhesion of uropathogenic p-fimbriated E. coli to uroepithelial cells in vitro. Proanthocyanidins are oligomeric flavonoids present in many botanicals and nutritional supplements. However, cranberry proanthocyanidins exhibit structural heterogeneity in the degree of polymerization, nature of interflavan bonds (A and B type), pattern of hydroxylation of flavan units and substitution with anthocyanins. This structural heterogeneity creates difficulty in structure to bioactivity. Biomedical research on the health benefits and risks of increased consumption of cranberry proanthocyanidins is severely limited by lack of information on structure/bioactivity relationships that can be used in standardization of cranberry products. Our core hypothesis is that the bioactivity of cranberry proanthocyanidin oligomers is a function of specific structure. Therefore, given the large diversity of individual oligomers, we would expect large variation in bioactivity. The goals of this proposal are: 1. Characterize structural heterogeneity (i.e. intra-molecular bonds, nature of the substitutions and degree of polymerization) of proanthocyanidin structures in the standardized NIH-NCCAM cranberry products using online and offline liquid chromatographic separations coupled with mass spectrometry, and 2. Relate the structural characteristics of the proanthocyanidin fractions to bioactivity in cell culture and in vitro models of inflammation, bacterial adherence and oxidation. We will carry out 3 types of experiments to characterize and prepare cranberry proanthocyanidins for assays of bioactivity; 1, experiments to optimize online and offline chromatography, 2, chemical degradation studies coupled with mass spectrometry of products to rapidly characterize structure, and 3, fragmentation studies using tandem mass spectrometry. We will then assay proanthocyanidin fractions for bioactivity using 3 methods; 1. Attenuation of LPS induced expression of cycloxygenase 2 in macrophages, 2. In vitro model of adherence of p-fimbriated E. coli to uroepithelial cells, and 3. specific association of proanthocyanidins to low density lipoproteins and inhibition of copper induced oxidation.
描述(由申请人提供):蔓越莓原花青素可能是导致蔓越莓汁消费与尿路感染风险降低之间相关性的成分,因为这些化合物可防止尿路致病性p-菌毛大肠杆菌的粘附。coli对体外培养的尿路上皮细胞的作用。原花青素是存在于许多植物和营养补充剂中的低聚类黄酮。然而,蔓越莓原花色素在聚合度、黄烷间键(A和B型)的性质、黄烷单元的羟基化模式和被花青素取代方面表现出结构异质性。这种结构异质性在结构与生物活性之间产生了困难。由于缺乏可用于蔓越莓产品标准化的结构/生物活性关系的信息,有关蔓越莓原花青素消费量增加的健康益处和风险的生物医学研究受到严重限制。我们的核心假设是蔓越莓原花青素低聚物的生物活性是特定结构的功能。因此,鉴于单个寡聚体的多样性很大,我们预计生物活性会有很大的变化。该提案的目标是:1。使用在线和离线液相色谱分离与质谱联用表征标准化NIH-NCCAM蔓越莓产品中原花青素结构的结构异质性(即分子内键、取代的性质和聚合度),以及2.将原花色素组分的结构特征与细胞培养和体外炎症、细菌粘附和氧化模型中的生物活性相关联。我们将进行3种类型的实验来表征和制备蔓越莓原花青素用于生物活性测定; 1,优化在线和离线色谱的实验,2,化学降解研究与产物质谱联用以快速表征结构,3,使用串联质谱的碎片化研究。然后,我们将使用3种方法测定原花青素级分的生物活性; 1.减弱LPS诱导的巨噬细胞环氧化酶2的表达。用体外粘附模型观察了p-菌毛E.大肠杆菌转化为尿路上皮细胞; 3.原花色素与低密度脂蛋白的特异性结合和铜诱导氧化的抑制。

项目成果

期刊论文数量(0)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)

数据更新时间:{{ journalArticles.updateTime }}

{{ item.title }}
{{ item.translation_title }}
  • DOI:
    {{ item.doi }}
  • 发表时间:
    {{ item.publish_year }}
  • 期刊:
  • 影响因子:
    {{ item.factor }}
  • 作者:
    {{ item.authors }}
  • 通讯作者:
    {{ item.author }}

数据更新时间:{{ journalArticles.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ monograph.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ sciAawards.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ conferencePapers.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ patent.updateTime }}

JESS D REED其他文献

JESS D REED的其他文献

{{ item.title }}
{{ item.translation_title }}
  • DOI:
    {{ item.doi }}
  • 发表时间:
    {{ item.publish_year }}
  • 期刊:
  • 影响因子:
    {{ item.factor }}
  • 作者:
    {{ item.authors }}
  • 通讯作者:
    {{ item.author }}

{{ truncateString('JESS D REED', 18)}}的其他基金

Bioactivity and structure for cranberry proanthocyanidins
蔓越莓原花青素的生物活性和结构
  • 批准号:
    7182283
  • 财政年份:
    2006
  • 资助金额:
    $ 17.84万
  • 项目类别:
Cranberry flavonoids and cardiovascular inflammation
蔓越莓类黄酮和心血管炎症
  • 批准号:
    7140066
  • 财政年份:
    2005
  • 资助金额:
    $ 17.84万
  • 项目类别:
TRAINING IN DMX ELECTRONICS & NMR
DMX 电子培训
  • 批准号:
    6120994
  • 财政年份:
    1999
  • 资助金额:
    $ 17.84万
  • 项目类别:
PROANTHOCYANIDINS & RELATED PHENOLICS IN ALFALFA & RED CLOVER
原花青素
  • 批准号:
    6120993
  • 财政年份:
    1999
  • 资助金额:
    $ 17.84万
  • 项目类别:

相似海外基金

How tensins transform focal adhesions into fibrillar adhesions and phase separate to form new adhesion signalling hubs.
张力蛋白如何将粘着斑转化为纤维状粘连并相分离以形成新的粘连信号中枢。
  • 批准号:
    BB/Y004841/1
  • 财政年份:
    2024
  • 资助金额:
    $ 17.84万
  • 项目类别:
    Research Grant
Defining a role for non-canonical mTORC1 activity at focal adhesions
定义非典型 mTORC1 活性在粘着斑中的作用
  • 批准号:
    BB/Y001427/1
  • 财政年份:
    2024
  • 资助金额:
    $ 17.84万
  • 项目类别:
    Research Grant
How tensins transform focal adhesions into fibrillar adhesions and phase separate to form new adhesion signalling hubs.
张力蛋白如何将粘着斑转化为纤维状粘连并相分离以形成新的粘连信号中枢。
  • 批准号:
    BB/Y005414/1
  • 财政年份:
    2024
  • 资助金额:
    $ 17.84万
  • 项目类别:
    Research Grant
Development of a single-use, ready-to-use, sterile, dual chamber, dual syringe sprayable hydrogel to prevent postsurgical cardiac adhesions.
开发一次性、即用型、无菌、双室、双注射器可喷雾水凝胶,以防止术后心脏粘连。
  • 批准号:
    10669829
  • 财政年份:
    2023
  • 资助金额:
    $ 17.84万
  • 项目类别:
Regulating axon guidance through local translation at adhesions
通过粘连处的局部翻译调节轴突引导
  • 批准号:
    10587090
  • 财政年份:
    2023
  • 资助金额:
    $ 17.84万
  • 项目类别:
Improving Maternal Outcomes of Cesarean Delivery with the Prevention of Postoperative Adhesions
通过预防术后粘连改善剖宫产的产妇结局
  • 批准号:
    10821599
  • 财政年份:
    2023
  • 资助金额:
    $ 17.84万
  • 项目类别:
Regulating axon guidance through local translation at adhesions
通过粘连处的局部翻译调节轴突引导
  • 批准号:
    10841832
  • 财政年份:
    2023
  • 资助金额:
    $ 17.84万
  • 项目类别:
Prevention of Intraabdominal Adhesions via Release of Novel Anti-Inflammatory from Surface Eroding Polymer Solid Barrier
通过从表面侵蚀聚合物固体屏障中释放新型抗炎剂来预防腹内粘连
  • 批准号:
    10532480
  • 财政年份:
    2022
  • 资助金额:
    $ 17.84万
  • 项目类别:
I-Corps: A Sprayable Tissue-Binding Hydrogel to Prevent Postsurgical Cardiac Adhesions
I-Corps:一种可喷雾的组织结合水凝胶,可防止术后心脏粘连
  • 批准号:
    10741261
  • 财政年份:
    2022
  • 资助金额:
    $ 17.84万
  • 项目类别:
Sprayable Polymer Blends for Prevention of Site Specific Surgical Adhesions
用于预防特定部位手术粘连的可喷涂聚合物共混物
  • 批准号:
    10674894
  • 财政年份:
    2022
  • 资助金额:
    $ 17.84万
  • 项目类别:
{{ showInfoDetail.title }}

作者:{{ showInfoDetail.author }}

知道了